Annalisa Orenti

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Pseudomonas Aeruginosa

Cystic Fibrosis

Drosophila Melanogaster

Top Venues

The European respiratory journal

Therapeutics and clinical risk management

ERJ open research

This page only lists publications with an associated author ORCID identifier.

Publications

Eitan Kerem, Annalisa Orenti, Arianna Adamoli, Elpis Hatziagorou, Lutz Naehrlich, Isabelle Sermet-Gaudelus, null null
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain. The European respiratory journal 63 (3) (2024)
Eitan Kerem, Annalisa Orenti, Arianna Adamoli, Elpis Hatziagorou, Lutz Naehrlich, Isabelle Sermet-Gaudelus, null null
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain. The European respiratory journal 63 (3) (2024)
Eitan Kerem, Annalisa Orenti, Arianna Adamoli, Elpis Hatziagorou, Lutz Naehrlich, Isabelle Sermet-Gaudelus, null null
Cystic fibrosis in Europe: improved lung function & longevity: reasons for cautious optimism, but challenges remain. The European respiratory journal (2024)
Eitan Kerem, Annalisa Orenti, Arianna Adamoli, Elpis Hatziagorou, Lutz Naehrlich, Isabelle Sermet-Gaudelus, null null
Cystic fibrosis in Europe: improved lung function and longevity - reasons for cautious optimism, but challenges remain. The European respiratory journal 63 (3) (2024)
Elpis Hatziagorou, Steffen Fieuws, Annalisa Orenti, Lutz Naehrlich, Uroš Krivec, Meir Mei-Zahav, Andreas Jung, Kris De Boeck, null null, null null
Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry. ERJ open research 9 (3) (2023)
Simone Gambazza, Annalisa Orenti, Giovanna Pizzamiglio, Anna Zolin, Carla Colombo, Dario Laquintana, Federico Ambrogi, null null
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry. Therapeutics and clinical risk management 19 (2023)
Simone Gambazza, Annalisa Orenti, Giovanna Pizzamiglio, Anna Zolin, Carla Colombo, Dario Laquintana, Federico Ambrogi, null null
Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry. Therapeutics and clinical risk management 19 (2023)
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, Elina Aleksejeva, Egil Bakkeheim, Vladimir Bobrovnichy, Siobhán B Carr, Carla Colombo, Harriet Corvol, Rebecca Cosgriff, Géraldine Daneau, Deniz Dogru Ersoz, Pavel Drevinek, Andrea Dugac Vukic, Isabelle Fajac, Alice Fox, Stojka Fustik, Vincent Gulmans, Satenik Harutyunyan, Elpis Hatziagorou, Irena Kasmi, Hana Kayserová, Elena Kondratyeva, Uroš Krivec, Halyna Makukh, Kestutis Malakauskas, Edward F McKone, Meir Mei-Zahav, Isabelle de Monestrol, Hanne Vebert Olesen, Rita Padoan, Tsitsino Parulava, Maria Dolores Pastor-Vivero, Luísa Pereira, Guergana Petrova, Andreas Pfleger, Liviu Pop, Jacqui G van Rens, Milan Rodic, Marc Schlesser, Valerie Storms, Oxana Turcu, Lukasz Woz Niacki, Panayiotis Yiallouros, Anna Zolin, Damian G Downey, Lutz Naehrlich
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe. ERJ open research 7 (4) (2021)
Edward F McKone, Cono Ariti, Abaigeal Jackson, Anna Zolin, Siobhán B Carr, Annalisa Orenti, Jacqui G van Rens, Lydie Lemonnier, Milan Macek, Ruth H Keogh, Lutz Naehrlich, null null, null null
Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study. The European respiratory journal 58 (3) (2021)